Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Confab is a prominent Canadian contract development and manufacturing organization (CDMO) that provides specialized services to the pharmaceutical and healthcare sectors. Established in 1979 and based in Saint-Hubert, Quebec, the company offers end-to-end solutions ranging from initial formulation development to large-scale commercial production. Their manufacturing expertise encompasses a wide array of dosage forms, including solid orals, non-sterile liquids, and semi-solid preparations such as creams and ointments. In 2014, the company was acquired by Mylan, which later merged with Pfizer's Upjohn division to form Viatris in 2020. As part of the Viatris network, Laboratoires Confab continues to operate as a high-standard GMP facility serving global markets. The site is recognized for its rigorous quality control and ability to handle complex manufacturing requirements for diverse therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Confab.